Mural Oncology to be acquired by XOMA Royalty for $2.035/share plus contingent consideration

Mural Oncology plc

Base cash price of $2.035 per share; potential additional up to $0.205 per share if closing net cash exceeds $36.2M estimate.
Closing expected by end of 2025, subject to shareholder vote and Irish High Court sanction.
Board unanimously recommends deal; directors (~0.42% ownership) give irrevocable undertakings to vote in favor.
All outstanding options and RSUs cancelled and converted into right to receive consideration per underlying share (net of exercise price).

item 1.01item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.